title: LRRK2-G2019S mutation is not associated with an increased cancer risk: a kin-cohort study.
authors.affiliation: Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Allegra
authors.forename: Sara
authors.initials: S
authors.lastname: Tunesi
authors.forename: Roberto
authors.initials: R
authors.lastname: Cilia
authors.forename: Gianni
authors.initials: G
authors.lastname: Pezzoli
authors.forename: Stefano
authors.initials: S
authors.lastname: Goldwurm
mesh_terms: D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D005998:Glycine / Q000235:genetics*; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D009154:Mutation / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012307:Risk Factors; D012694:Serine / Q000235:genetics*; D035781:Siblings
chemical_list: D012694:Serine; C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases; D005998:Glycine